2020 TOPIC AREAS

CLINICAL DEVELOPMENT/ REGULATORY

WHO ATTENDS

Pharma, biotechs

• VP Clinical Development
• Chief Medical Officer
• Chief Scientific Officer
• Regulatory Affairs
• President, Head of Rare Diseases

TOPICS AREAS

• Patient centric clinical development
• Clinical trial design
• Real World Evidence in clinical development
• Expanded Access Programs / Managed
• Access Programs

WHO SHOULD SPONSOR

Contract Research Organizations (CROs)

Contract Development and Manufacturing Organizations (CDMOs)

Clinical Trials Services

Home Clinical Trials

Patient Recruitment & Identification

Regulatory Consulting

COMMERCIALIZATION

WHO ATTENDS

Pharma, biotechs

• Chief Commercial Officer
• VP Commercial Operations
• VP of Marketing
• VP Medical Affairs

TOPICS AREAS

• Business models
• Forecasting and Epidemiology
• Global expansion and internationalization
• Business development

WHO SHOULD SPONSOR

Specialty Pharmacy

Logistics, Supply Chain, 3PL

Strategic Consulting

Real World Evidence

Forecasting and Epidemiology

Marketing, Communications Agency

Market Research

Data analytics platforms

RARE DISEASE ADVOCACY WORLD

WHO ATTENDS

Pharma, biotechs

• Chief Patient Officer
• VP Patient Advocacy
• Medical Affairs
• Patient Engagement

Patient Advocacy Groups

TOPICS AREAS

• Patient Data
• Patient Registries & Patient Reported Outcomes (PROs)
• Evolving role of patient groups in R&D
• Genetic testing & diagnosis
• Advocacy & Policy
• Setting up patient groups
• Industry collaboration

WHO SHOULD SPONSOR

Pharma & biotechs

Research Institutions

Patient Registries

Patient Engagement Platforms

Genetic Testing providers

Genomic Sequencing Platforms

Diagnostics

GLOBAL PATIENT AND MARKET ACCESS

WHO ATTENDS

Pharma, biotechs

• VP Market Access
• Pricing and Reimbursement
• Chief Commercial Officer
• International Business

Regulatory

Government

• Ministry of Health
• Policy makers

TOPICS AREAS

• Market entry strategies
• Stakeholder collaboration for market access
• Real World Evidence
• Improving access
• International regulation

WHO SHOULD SPONSOR

Multinational and foreign Contract Research Organizations (CROs)

Market Access Consulting

Pricing & Reimbursement Consulting

Licensing

Government agencies

Distributors

PRICING & REIMBURSEMENT

WHO ATTENDS

Pharma, biotechs

• Chief Executive Officer
• VP, Head of Market Access
• VP, Head of Pricing and Reimbursement
• VP of Health Economics/HEOR
• VP of HTA
• Head of Value Demonstration
• VP, Evidence and Data

Payers (public and private)

Government & Regulatory agencies

TOPICS AREAS

• Advanced therapies pricing & reimbursement
• Real World Evidence
• Health Technology Assessment
• Value Based Assessment
• Next generation pricing and innovative pricing models

WHO SHOULD SPONSOR

PRO consultancies and PRO technology providers

Value communication organizations

Pricing & Reimbursement consulting firms

HEOR service providers

Patient registries and database providers

RARE ONCOLOGY

WHO ATTENDS

Pharma, biotechs

• VP Cell Therapy
• Head of Oncology
• Head of Immunotherapy
• Chief Medical Officer

TOPICS AREAS

• Diagnosis
• Biomarker R&D
• CAR-T development
• Advocacy and patient voice
• Clinical development and commercialization

WHO SHOULD SPONSOR

Immunoncology pharma and biotechs

Contract Manufacturing Organizations (CMOs)

Contract Research Organizations (CROs)

Genomic/DNA sequencing

ADVANCED THERAPIES CLINICAL DEVELOPMENT

WHO ATTENDS

Pharma, biotechs

• VP Gene Therapy
• Chief Medical Officer
• Chief Manufacturing Officer
• Chief Scientific Officer
• VP Manufacturing &
• Technical Operations

TOPICS AREAS

• Gene therapy development
• Cell therapy development
• Translational science and path to clinical trials
• Regulation

WHO SHOULD SPONSOR

Advanced therapies pharma & biotechs

Gene Editing biotechs

Contract Research Organizations (CROs)

Clinical trial design

ADVANCED THERAPIES MANUFACTURING

WHO ATTENDS

Pharma, biotechs

• Chief Operating Officer
• Chief Manufacturing & Technology Officer
• VP Technical Operations
• VP of CMC
• VP Manufacturing
• VP of Process Development
• VP of Quality Control

TOPICS AREAS

• Process development
• Outsourcing
• Viral vector development
• Manufacturing efficiency and capacity
• Analytical development
• Quality Control

WHO SHOULD SPONSOR

Contract Manufacturing Organizations (CMOs)

Viral Vector Development and Manufacturing

GMP, nonGMP process development

ADVANCED THERAPIES COMMERCIALIZATION (NEW)

WHO ATTENDS

Pharma, biotechs

• Head of Commercial Operations
• Chief Commercial Officer
• Licensing Officer
• VP, Supply Chain and Distribution
• VP, Cell and Gene Therapy Business
• Head of CAR-T Unit
• Head of R&D
• VP of Quality Control

Hospitals and healthcare centers

TOPICS AREAS

• Access & coverage
• Distribution and supply chain
• Demand forecasting
• Pricing and contracting models
• Regulation

WHO SHOULD SPONSOR

Specialty pharmacy

Supply chain and distribution

Cell sourcing, delivery and logistics

Cell therapy supply chain

Clinical research support

Cell line providers

Biorepository & sample access

Collection network management

Quality & regulatory services

DIGITAL HEALTH AND ARTIFICIAL INTELLIGENCE (NEW)

WHO ATTENDS

Pharma, biotechs

• Chief Data Officer
• Chief Technology Officer
• Chief Operating Officer
• VP, Analytics
• Head of Innovation
• Head of Digital

Hospitals and healthcare centers

Payers

TOPICS AREAS

• AI in drug discovery
• Patient identification
• Data analytics
• Data collection through wearables and applications

WHO SHOULD SPONSOR

Artificial Intelligence platforms

Patient identification solutions

Machine learning

Data analytics

Wearable technology

Digital Health Apps

Patient registries

PITCH & PARTNER

WHO ATTENDS

Pharma, biotechs

• CEO
• Presidents
• Chief Business Officer
• VP Business Development
• VP External Innovation
• VP R&D

Venture Capital Firms

Grant Agencies (Public and Private)

Licensing pharma

TOPICS AREAS

• Advanced therapies investment
• Risk assessment
• Partnering and co-development opportunities
• Funding
• Accelerating orphan drug development
• Successful case studies

WHO SHOULD SPONSOR

Investment Banks

Pharma & Biotechs

Venture Capital Firms

Grant Agencies (Public and Private)

Contract Research Organizations (CROs)